Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating rapid expansion of tumor-infiltrating lymphocytes (TILs) to treat metastatic pleural disease, including malignant pleural effu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIL therapy (tumor-infiltrating lymphocyte therapy)

Snippet

Sponsor: David Bartlett, MD | Conditions: Malignant Pleural Effusion, Malignant Mesothelioma | Phase 1 | Status: RECRUITING